Pfizer Says Its COVID-19 Pill Reduces Death, Hospitalization Risk by 89%; Will Submit for FDA Approval Pfizer says that its COVID-19 pill reduced the risk of hospitalization or death by 89 percent in a clinical trial involving adults “at...

PM and health minister reach agreement with drug company for ‘tens of thousands of doses’; initial data shows almost 90% efficacy Pfizer has pledged a shipment of its experimental antiviral COVID-19 pill to Israel, according to a Saturday...

By MATTHEW PERRONE  November 5, 2021 WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for...

Big news today from Omnyx in partnership with the White House Office of Science of Technology Policy, American Society for Clinical Pathology, American Cancer Society, Union International Cancer Control, Sakura, Roche and Pfizer. ASCP...